NextCell Pharma AB NXTCL.ST Stock
2.85 SEK
{{ price }}
-3.716221%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
97.98M SEK
LOW - HIGH [24H]
2.85
-
3 SEK
VOLUME [24H]
2.25K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-1.18 SEK
NextCell Pharma AB Price Chart
NextCell Pharma AB NXTCL.ST Financial and Trading Overview
| NextCell Pharma AB stock price | 2.85 SEK |
| Previous Close | 4.49 SEK |
| Open | 4.46 SEK |
| Bid | 4.5 SEK x N/A |
| Ask | 4.6 SEK x N/A |
| Day's Range | 4.46 - 4.76 SEK |
| 52 Week Range | 3.77 - 8.95 SEK |
| Volume | 21.61K SEK |
| Avg. Volume | 27.36K SEK |
| Market Cap | 154.71M SEK |
| Beta (5Y Monthly) | 0.529885 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.18 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NXTCL.ST Valuation Measures
| Enterprise Value | 76.75M SEK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 17.603773 |
| Price/Book (mrq) | 1.6251354 |
| Enterprise Value/Revenue | 8.733 |
| Enterprise Value/EBITDA | -1.997 |
Trading Information
NextCell Pharma AB Stock Price History
| Beta (5Y Monthly) | 0.529885 |
| 52-Week Change | -35.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.95 SEK |
| 52 Week Low | 3.77 SEK |
| 50-Day Moving Average | 5.46 SEK |
| 200-Day Moving Average | 6.53 SEK |
NXTCL.ST Share Statistics
| Avg. Volume (3 month) | 27.36K SEK |
| Avg. Daily Volume (10-Days) | 40.42K SEK |
| Shares Outstanding | 34.38M |
| Float | 23.34M |
| Short Ratio | N/A |
| % Held by Insiders | 42.82% |
| % Held by Institutions | 5.27% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | August 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -442.40% |
| Gross Margin | -9.38% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.59% |
| Return on Equity (ttm) | -33.41% |
Income Statement
| Revenue (ttm) | 8.79M SEK |
| Revenue Per Share (ttm) | 0.26 SEK |
| Quarterly Revenue Growth (yoy) | 48.60% |
| Gross Profit (ttm) | -2493528 SEK |
| EBITDA | -38439392 SEK |
| Net Income Avi to Common (ttm) | -38196540 SEK |
| Diluted EPS (ttm) | -1.2 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 77.62M SEK |
| Total Cash Per Share (mrq) | 2.26 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 9.887 |
| Book Value Per Share (mrq) | 2.769 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -31997116 SEK |
| Levered Free Cash Flow (ttm) | -27420292 SEK |
Profile of NextCell Pharma AB
| Country | Sweden |
| State | N/A |
| City | Huddinge |
| Address | Karolinska Institutet Science Park |
| ZIP | 141 57 |
| Phone | 46 87 35 55 95 |
| Website | https://www.nextcellpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 15 |
NextCell Pharma AB, a biopharmaceutical company, engages in the research, development, and manufacture of novel stem cell therapies in Sweden. The company develops ProTrans, a drug candidate that consists of stem cells for the treatment of autoimmune disease, including type-1 diabetes. It also operates Cellaviva, a stem cell bank. The company was incorporated in 2014 and is based in Huddinge, Sweden.
Q&A For NextCell Pharma AB Stock
What is a current NXTCL.ST stock price?
NextCell Pharma AB NXTCL.ST stock price today per share is 2.85 SEK.
How to purchase NextCell Pharma AB stock?
You can buy NXTCL.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NextCell Pharma AB?
The stock symbol or ticker of NextCell Pharma AB is NXTCL.ST.
Which industry does the NextCell Pharma AB company belong to?
The NextCell Pharma AB industry is Biotechnology.
How many shares does NextCell Pharma AB have in circulation?
The max supply of NextCell Pharma AB shares is 34.38M.
What is NextCell Pharma AB Price to Earnings Ratio (PE Ratio)?
NextCell Pharma AB PE Ratio is now.
What was NextCell Pharma AB earnings per share over the trailing 12 months (TTM)?
NextCell Pharma AB EPS is -1.18 SEK over the trailing 12 months.
Which sector does the NextCell Pharma AB company belong to?
The NextCell Pharma AB sector is Healthcare.
NextCell Pharma AB NXTCL.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North Sweden SEK GI FNSESEKGI | 1956.89 SEK 191.02 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1570.14 EUR 1716.38 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care GI FN20GI | 917.04 EUR 1002.44 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 97.9 EUR 107.01 USD |
-0.64
|
— — | — — | — — | — - | — — |
| First North Sweden SEK PI FNSESEKPI | 1843.91 SEK 179.99 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1479.5 EUR 1617.29 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care PI FN20PI | 912.9 EUR 997.92 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 123.34 SEK 12.04 USD |
-0.14
|
— — | — — | — — | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 97.96 DKK 14.36 USD |
-0.62
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}